News & Events
News
Study shows nanofiber scaffolds could treat lymphedema by rerouting lymphatic system around blockage
Researchers at the School of Medicine have developed a possible treatment for lymphedema, the severe swelling of an arm or leg that can occur when the lymph system is blocked. Using scaffolding composed of specially patterned collagen nanofibers, the researchers...
Fibralign wins BSK biotech startup competition!
Wins $30,000 first place prize among >150 amazing startups in CA event held April 7th at Stanford Medical school. Sponsored by BioSciKin, a Chinese biotech venture focused on precision medicine. See full article at http://califesciences.org/bioscikin-1/. Fibralign...
BioBridge® Collagen Matrix receives 510(k) clearance
Fibralign's first product, the BioBridge® Collagen Matrix has received 510(k) clearance from the FDA on January 07, 2016 for use in soft tissue support/repair (K151083). Click to view. BioBridge is a sterile thread-like surgical mesh designed for use in surgery to...
Conferences
Fibralign and its research collaborators have made over 100 presentations related to BioBridge and Nanoweave scientific findings at international leading medical research conferences. Fibralign and its distributors also exhibit at international conferences in Europe and Asia.
